Glancy prongay & murray llp, a leading securities fraud law firm, announces the filing of a securities class action on behalf of y-mabs therapeutics, inc. (ymab) investors

Los angeles--( business wire )--glancy prongay & murray llp (“gpm”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired y-mabs therapeutics, inc. (“y-mabs” or the “company”) (nasdaq: ymab) common stock between october 6, 2020 and october 28, 2022, inclusive (the “class period”). y-mabs investors have until march 20, 2023 to file a lead plaintiff motion.
YMAB Ratings Summary
YMAB Quant Ranking